Enveric Biosciences (SPZR) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Psychedelic: Enveric, Filament Health report earnings resultsApril 3, 2025 | markets.businessinsider.comEnveric Biosciences Participating in BIO-Europe Spring®March 17, 2025 | financialpost.comEnveric Biosciences Participating in BIO-Europe Spring®March 17, 2025 | financialpost.comEnveric Biosciences, Inc. (ENVB) Seeks Buyers for PsyAI Trademark Amid Shift to Neuroplastogen DevelopmentMarch 7, 2025 | insidermonkey.comEnveric Biosciences, Inc. (ENVB) Seeks Buyers for PsyAI Trademark Amid Shift to Neuroplastogen DevelopmentMarch 7, 2025 | msn.comEnveric CEO says company is ‘at the forefront’ of neuroplastogens fieldFebruary 27, 2025 | msn.comEnveric Passes Key Milestone on Patent Path for Mental-Health TreatmentJanuary 30, 2025 | marketwatch.comEnveric Biosciences gets Notice of Allowance for EB-003 from USPTOJanuary 30, 2025 | markets.businessinsider.comEnveric Biosciences 1.67M share Spot Secondary priced at $3.00January 30, 2025 | markets.businessinsider.comEnveric Biosciences stock hits 52-week low at $0.29January 28, 2025 | msn.comEnveric Biosciences trading halted, news pendingJanuary 25, 2025 | markets.businessinsider.comEnveric Biosciences Announces 1-for-15 Reverse Stock SplitJanuary 21, 2025 | msn.comEnveric Biosciences to Release Investor PresentationJanuary 3, 2025 | tipranks.comEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNovember 25, 2024 | financialpost.comEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNovember 25, 2024 | financialpost.comEnveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health DisordersNovember 18, 2024 | benzinga.comEnveric Biosciences (NASDAQ:ENVB) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comNon-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough ResearchSeptember 25, 2024 | benzinga.comWhy Is Enveric Biosciences (ENVB) Stock Up 18% Today?July 30, 2024 | investorplace.comENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024May 20, 2024 | investorplace.comEnveric Biosciences to out-license psilocin prodrug to MindBioMay 15, 2024 | msn.comEnveric Biosciences (ENVB) Price Target Decreased by 11.11% to 8.16April 18, 2024 | msn.comEnveric Biosciences Shares Pop 20% After Out-Licensing Deals Valued Up to $82MMarch 19, 2024 | marketwatch.comWhy Enveric Biosciences Stock Is SoaringFebruary 29, 2024 | msn.comEXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug CompoundsFebruary 29, 2024 | msn.comEnveric Biosciences (ENVB) Price Target Increased by 5.88% to 9.18February 25, 2024 | msn.comEnveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health TreatmentsFebruary 23, 2024 | msn.comEnveric Biosciences to Sell Cannabinoid-Related IPFebruary 23, 2024 | marketwatch.comPacira BioSciences Inc.February 13, 2024 | wsj.comEnveric Biosciences initiated with bullish view at H.C. Wainwright, here's whyJanuary 30, 2024 | realmoney.thestreet.comEnveric Biosciences files to sell 2.24M shares for holdersJanuary 11, 2024 | msn.comEnveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical TrialsNovember 14, 2023 | benzinga.comEnveric Biosciences files to sell 1.2M shares for holdersNovember 8, 2023 | msn.comBoosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety TreatmentAugust 28, 2023 | benzinga.comEnveric Biosciences Reports Positive Results From Animal Studies With EB-373July 17, 2023 | markets.businessinsider.comWhy Is Enveric Biosciences (ENVB) Stock Up 120% Today?May 18, 2023 | msn.comEnveric Biosciences Shares Rise 40% After Notice of Allowance for Psilocin U.S. PatentMay 18, 2023 | marketwatch.comEnveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of PsilocinMay 18, 2023 | msn.comEnveric soars ~130% on upcoming US patent linked to psilocin prodrug EB-373 for anxietyMay 18, 2023 | msn.comEnveric Biosciences Plans About 35 Percent Reduction In Full-time PersonnelMay 15, 2023 | markets.businessinsider.comEnveric Biosciences Reports First Quarter 2023 Financial Results and Operational HighlightsMay 15, 2023 | benzinga.comEXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing BenefitsApril 20, 2023 | msn.comEnveric Biosciences GAAP EPS of -$13.00 misses by $0.54April 3, 2023 | seekingalpha.comEnveric Biosciences gets new finance chiefMarch 1, 2023 | msn.comEnveric Biosciences Appoints New Independent DirectorsJuly 27, 2022 | apnews.comEnveric to spin out cannabinoid pipeline into a public companyMay 11, 2022 | seekingalpha.com Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPZR and its competitors with MarketBeat's FREE daily newsletter. Email Address SPZR Media Mentions By Week SPZR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPZR News Sentiment▼0.000.65▲Average Computer and Technology News Sentiment SPZR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPZR Articles This Week▼00▲SPZR Articles Average Week Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPZR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OCQLF News ACEYY News ADYYF News LIDRW News ABWN News AISPW News AIXXF News AWEVF News AAIRF News AMPGW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SPZR) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPZR Stock Free SPZR Stock Alerts